Pyrvinium Treatment Confers Hepatic Metabolic Benefits via beta-Catenin Downregulation and AMPK Activation.

Zhou S, Obianom ON, Huang J, Guo D, Yang H, Li Q, Shu Y
Pharmaceutics. 2021 Mar 4;13(3). pii: pharmaceutics13030330. doi: 10.3390/pharmaceutics13030330. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.